Viewing StudyNCT00463021



Ignite Creation Date: 2024-05-05 @ 5:29 PM
Last Modification Date: 2024-10-26 @ 9:32 AM
Study NCT ID: NCT00463021
Status: COMPLETED
Last Update Posted: 2015-05-05
First Post: 2007-04-18

Brief Title: A Phase 4 Study to Determine Dosing of Hectorol Capsules When Converting From Zemplar Injection
Sponsor: Genzyme a Sanofi Company
Organization: Sanofi

Conditions & Keywords Data

Conditions:
Name
Secondary Hyperparathyroidism
Keywords:
Name View
Zemplar paricalcitol injection View
Hectorol doxercalciferol capsules View